About Us

Bacteria Beyond Borders

through a variety of programs: AMR specific CME courses for clinicians and pharmacists, making educational materials available to patients in clinical settings and via social media, conducting community-oriented educational fundraising events, and working with a wide range of government agencies to take immediate action in the promotion of antibiotic stewardship.

by making NGS technology accessible to clinicians and patients, and assisting patients who are suffering with infections with a plan of action for complete recovery.

for healthcare facilities that will combat ESKAPE pathogens colonizing on surfaces and in medical equipment, helping to eliminate the chance of further infections.

by creating educational materials about advanced diagnostic methods which will aid in patient outcomes of phage therapy treatment. We’ll create a Phage-Bacteria Binding Site Database to be used in conjunction with NGS to determine optimal phage monotherapy or cocktail therapy.

providing NGS diagnostic kits to patients enrolled in clinical trials for phage therapy and for patients enrolled in clinical trials for new antibiotic treatments.  It is imperative to identify the exact cause of any infection in order to provide accurate treatments.  Supporting these trials with NGS will help to determine what pathogens are present before treatment is administered.  This protocol reinforces antibiotic stewardship for all involved.

Bacteria Beyond Borders is dedicated to raising global awareness of antimicrobial resistance (AMR) with an emphasis on bacterial antibiotic resistance. Our mission is to educate the public and healthcare professionals about AMR, its causes, and strategies for reduction and elimination.

We will achieve this through a variety of initiatives: 

Our vision is to save the world one infection at a time, promoting antibiotic stewardship and responsible treatment practices among all people. We aim to stop antibiotic resistance from becoming the #1 cause of death worldwide by implementing innovative molecular diagnostics and advancing alternative therapies and treatments.

Our mission serves all people, focusing on those affected by infections, partnering with medical and technological experts, and engaging investors to support our cause. Together, we strive to create a world where AMR is significantly reduced by making accurate treatments accessible to all.

Our Board of Directors

Tara Hicks

Founder/President

Aaron Hicks

Vice President/Secretary

Sharon McDonough

Treasurer

Emmanuelle Houjib, PA-C

Board Member

Nicholas Sanford, Ph.D, BCMAS

Biotech and Molecular Expert, Board Member

Dr. James Ian McMillen, MD, FIDSA

Infectious Disease Specialist, Board Member

Join Our Newsletter

Please enable JavaScript in your browser to complete this form.
Name